Fibrosis progression in paired liver biopsies from HIV/HCV co-infected patients.

Abstract

Our findings highlight that in HIV/HCV coinfected patients, an effective antiretroviral therapy that assures a good immune-virological profile contributes to reducing the risk of LFP.